Webinar on lipids and oncology, presented by Dr. Catherine Field and Dr. Robert Chapkin, two of the world’s leading experts in the molecular mechanisms by which lipids modulate cancer risk and therapy. Together with DSM’s Dr. Keri Marshall, they will discuss the evidence for the use of lipids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as a part of neoadjuvant therapy for two of the most common cancers: breast and colon. Click Here for Webinar.
An interdisciplinary team of researchers at Texas A&M University has been awarded a Division of Computing and Communication Foundations grant by the National Science Foundation to develop a gut-microbial investigation model that can identify critical dietary risk factors that cause colorectal cancer. The three-year, $350,000 project is a direct outcome of Texas A&M Engineering Experiment Station’s Interdisciplinary Seed Grants for Strategic Initiatives, which provided initial funding to establish the collaborative research effort. Continue Reading…
The Huffines Institute at Texas A&M University hosted Dr. Chapkin on their Friday Podcast. Dr. Chapkin discussed his work with Dietary Chemo-prevention, Dietary methods, and Chronic Disease. If you are looking at how beneficial nutrition can be to cancer prevention this conversation is for you! LISTEN NOW
*Transcript will be available here.
Colon cancer ranks second among cancers both in mortality (nearly 60,000 cases annually) and frequency of detection (more than 150,00o cases annually) in America. Read more here.
The Vice Chancellor’s Award in Excellence recognizes the commitment and outstanding contributions of faculty and staff across Texas A&M AgriLife. The award was presented Jan. 14 at the AgriLife Center on the Texas A&M University campus in College Station.
View article here.